Dr. Yanping Kong, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Essex Center Dr, Peabody, MA 01960 Phone: 781-744-8000 |
Helen Kaulbach, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27 Centennial Dr, Peabody, MA 01960 Phone: 978-531-7677 Fax: 978-531-7690 |
Jennifer C Braimon, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: One Essex Center Drive, Lahey Clinic, Peabody, MA 01960 Phone: 978-977-6336 Fax: 978-538-4712 |
David William Toth, M.D., FACE Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 89 Foster St, Peabody, MA 01960 Phone: 978-532-4903 |
News Archive
Omeros Corporation today announced that it has submitted to the U.S. Food and Drug Administration (FDA) an investigational new drug (IND) application to initiate the Phase 2 clinical program for OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin‑associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system.
Reverse Medical Corporation today announced the initial clinical use of their MVP Micro Vascular Plug system for peripheral artery embolization. The device has been granted CE Mark approval to obstruct or reduce the rate of blood flow in the peripheral vasculature.
An editorial challenges physicians and the U.S. healthcare system to reconsider the current "one size fits all" care for diverticulitis and to employ a precision medicine approach to determine which patients should be referred for colonoscopy.
A USC review of published research has found no evidence that early episodes of schizophrenia without medication result in long-term harm for patients, casting doubt on the practice to immediately medicate for a year.
› Verified 9 days ago